(Date:12/11/2009)... OSLO, December 11 Algeta ASA ... the first clinical center in the,US, the ... randomizing patients,in the phase III clinical study ... as hormone-refractory) prostate cancer,(CRPC) that has metastasized ... The ALSYMPCA (ALpharadin in SYMptomatic Prostate ...
(Date:12/11/2009)... CAMBRIDGE, Mass., Dec. 11 Gwathmey, ... company specializing in cancer, staph aureus, and cardiovascular ... Pre-clinical Services announced today that Rosalie Dunn, Ph.D., ... Dr. Dunn has over 28 years of experience ... Prior to joining Gwathmey, Dr. Dunn managed ...
(Date:12/11/2009)... 11, 2009 -- Esco announces the opening of a NEW 2nd ... a technical service, training and logistics center to support Esco,s growth ... Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... of a NEW 2nd North American facility in Marietta, OH. The ...
(Date:12/10/2009)... Microban International, Ltd., the global ... partnered with Sharp Imaging and Information Company ... to incorporate it,s third generation silver-based antimicrobial ... into the calculator keys during manufacture, Microban ... of damaging bacteria on the keys. ...
Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2... Novavax, Inc.,(Nasdaq: NVAX ) and the ... from a preclinical study of a Respiratory Syncytial ... worldwide rights from the, University of Massachusetts Medical ... commercialization of Paramyxovirus vaccines incorporating,certain Virus-Like-Particles ("VLPs"). ...
... NOVATO, Calif., Dec. 9 BioMarin Pharmaceutical,Inc. ... that its partner Merck Serono, a division,of ... approval for,Kuvan(R) (sapropterin dihydrochloride) for the treatment ... deficient patients,from the European Commission. Merck ...
... favorable results from a Phase 1 vehicle-controlled study of ... during urological surgery. , , ... patients undergoing endoscopic removal of urinary stones, and was ... the drug product. The pharmacokinetic data from this study ...
Other Biology Technology:NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 2NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 3NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 4Kuvan Receives Marketing Approval in the European Union 2Kuvan Receives Marketing Approval in the European Union 3Kuvan Receives Marketing Approval in the European Union 4Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery 2... (Klenow) Fragment, Exonuclease Minus, is a DNA-dependent ... and the 3´→5´ exonuclease activities present in ... It is used for random primer labeling ... Klenow Fragment, Exonuclease Minus, will leave a ...
Goat polyclonal to Duffy / FY / DARC...
... The Centra-CL5R multi-purpose centrifuge offers both ... large assortment of rotor options, making ... laboratory applications., Maximum Versatility , ... xg) angle rotors or high-volume (4 x ...
... The H2OBIT is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
Biology Products:Biology NavigationMedical Navigation